1370 related articles for article (PubMed ID: 18671239)
21. The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma.
Al-Shibli K; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
APMIS; 2010 May; 118(5):371-82. PubMed ID: 20477813
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
23. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito Y; Saito K; Shiiba K; Ohuchi A; Saigenji K; Nagura H; Ohtani H
Cancer Res; 1998 Aug; 58(16):3491-4. PubMed ID: 9721846
[TBL] [Abstract][Full Text] [Related]
24. Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer.
Donnem T; Al-Shibli K; Andersen S; Al-Saad S; Busund LT; Bremnes RM
Cancer; 2010 Sep; 116(18):4318-25. PubMed ID: 20549821
[TBL] [Abstract][Full Text] [Related]
25. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.
Welsh TJ; Green RH; Richardson D; Waller DA; O'Byrne KJ; Bradding P
J Clin Oncol; 2005 Dec; 23(35):8959-67. PubMed ID: 16219934
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of the lymphocyte-to-neutrophil ratio in percutaneous fine-needle aspiration biopsy specimens of advanced nonsmall cell lung carcinoma.
Nakahara Y; Mochiduki Y; Miyamoto Y; Nakahara Y; Katsura Y
Cancer; 2005 Sep; 104(6):1271-80. PubMed ID: 16047345
[TBL] [Abstract][Full Text] [Related]
27. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y
Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
[TBL] [Abstract][Full Text] [Related]
28. Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.
Vollmer RT; Govindan R; Graziano SL; Gamble G; Garst J; Kelley MJ; Christenson RH
Clin Cancer Res; 2003 May; 9(5):1728-33. PubMed ID: 12738727
[TBL] [Abstract][Full Text] [Related]
29. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients.
Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Suzuki N; Inoue M; Soma G; Nagasue N
Anticancer Res; 2003; 23(6D):5015-22. PubMed ID: 14981961
[TBL] [Abstract][Full Text] [Related]
30. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.
Zhang Z; Xu F; Wang S; Li N; Wang C
Lung Cancer; 2008 Jun; 60(3):434-40. PubMed ID: 18036699
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
32. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.
Petersen RP; Campa MJ; Sperlazza J; Conlon D; Joshi MB; Harpole DH; Patz EF
Cancer; 2006 Dec; 107(12):2866-72. PubMed ID: 17099880
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
[TBL] [Abstract][Full Text] [Related]
34. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.
Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Ohno Y; Suzuki N; Inoue M; Soma G; Nagasue N
Anticancer Res; 2005; 25(1B):463-70. PubMed ID: 15816613
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma.
Schleusener JT; Tazelaar HD; Jung SH; Cha SS; Cera PJ; Myers JL; Creagan ET; Goldberg RM; Marschke RF
Cancer; 1996 Apr; 77(7):1284-91. PubMed ID: 8608504
[TBL] [Abstract][Full Text] [Related]
36. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
[TBL] [Abstract][Full Text] [Related]
37. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
[TBL] [Abstract][Full Text] [Related]
38. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
Mandrekar SJ; Schild SE; Hillman SL; Allen KL; Marks RS; Mailliard JA; Krook JE; Maksymiuk AW; Chansky K; Kelly K; Adjei AA; Jett JR
Cancer; 2006 Aug; 107(4):781-92. PubMed ID: 16847887
[TBL] [Abstract][Full Text] [Related]
39. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.
Ilie M; Hofman V; Ortholan C; Bonnetaud C; Coëlle C; Mouroux J; Hofman P
Cancer; 2012 Mar; 118(6):1726-37. PubMed ID: 21953630
[TBL] [Abstract][Full Text] [Related]
40. Gender differences in treatment outcomes among patients with non-small cell lung cancer given a combination of carboplatin and paclitaxel.
Yamamoto H; Sekine I; Yamada K; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Oncology; 2008; 75(3-4):169-74. PubMed ID: 18827494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
